Newsroom
-
January 23 , 2024
Sanofi to Acquire Inhibrx, Inc., Adding Potential Best-in-class Rare Disease Asset for Alpha-1 Antitrypsin Deficiency to Pipeline
Read more -
January 5 , 2024
MediLink Therapeutics and Roche Reach Exclusive Global License Agreement to Collaborate on the Development of Next-generation ADC for Cancer Treatment
Read more -
January 2 , 2024
U.S. FDA Approves Label Update For Kite’s Yescarta® CAR T-Cell Therapy To Include Overall Survival Data
Read more -
December 27 , 2023
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
Read more -
December 25 , 2023
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
Read more -
December 18 , 2023
FDA approves enfortumab vedotin-ejfv (Padcev) with pembrolizumab (Keytruda) for locally advanced or metastatic urothelial cancer
Read more